This announcement is a separate document:
麗珠醫藥：(I)二零二二年度利潤分配預案 (II)建議授信融資暨為下屬附屬公司提供融資擔保 (III)建議繼續實施回購本公司部分A股股份方案 (IV)建議重選本公司董事及監事 (V)建議本公司董事袍金及監事袍金 (VI)召開年度股東大會、 A股類別股東會及H股類別股東會
LIVZON PHARMA: (I) 2022 ANNUAL PROFIT DISTRIBUTION PLAN (II) PROPOSED FACILITY FINANCING AND PROVISION OF FINANCING GUARANTEES TO SUBSIDIARIES (III) PROPOSED RENEWAL OF THE REPURCHASE OF PART OF THE COMPANY''S A SHARES SCHEME (IV) PROPOSED RE-ELECTION OF D
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.